WS7.3 Once-daily liposomal amikacin for inhalation is noninferior to twice-daily tobramycin inhalation solution in improving pulmonary function in cystic fibrosis patients with chronic infection due to Pseudomonas aeruginosa
| Autor: | Bilton, D., Pressler, T., Fajac, I., Clancy, J.P., Sands, D., Minic, P., Cipolli, M., La Rosa, M., Galeva, I., Solé, A., Dupont, L., Goss, C.H., Mayer-Hamblett, N., Quittner, A.L., Constantine, S., Gupta, R., Konstan, M. |
|---|---|
| Zdroj: | In Journal of Cystic Fibrosis June 2014 13 Supplement 2:S15-S15 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect